No increase in risk of pneumonia in budesonide

There has been ongoing concern about the use of inhaled steroids in COPD increases the risk of pneumonia. This meta-analysis does not support an association between the use of inhaled budesonide and pneumonia (abstract).

Danielle Scheurer

Dr. Scheurer is a clinical hospitalist and the Medical Director of Quality and Safety at the Medical University of South Carolina in Charleston, South Carolina, and is Assistant Professor of Medicine. She is a graduate of the University of Tennessee College of Medicine, completed her residency at Duke University, and completed her Masters in Clinical Research at the Medical University of South Carolina. She also serves as the Web Editor and Physician Advisor for the Society of Hospital Medicine.

Leave a Comment